BFRI: Biofrontera Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8.21
Enterprise Value ($M) 5.34
Book Value ($M) 5.53
Book Value / Share 0.71
Price / Book 1.49
NCAV ($M) 3.94
NCAV / Share 0.51
Price / NCAV 2.08

Profitability (mra)
Return on Invested Capital (ROIC) -1.97
Return on Assets (ROA) -0.46
Return on Equity (ROE) -2.68

Liquidity (mrq)
Quick Ratio 0.94
Current Ratio 1.53

Balance Sheet (mrq) ($M)
Current Assets 16.93
Assets 18.52
Liabilities 12.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
5 days ago 13G/A Hirschman Orin
12-20 13D/A Deutsche Balaton Aktiengesellschaft
11-14 13G/A Armistice Capital, Llc 4.99 73.19
11-14 13G/A Lytton Laurence W 9.99 9.04
11-13 13G/A Saad Nabil 0.00 -100.00
11-06 13G/A Rosalind Advisors, Inc. 6.90 -14.02
11-01 13G/A Bigger Capital, LLC -98.01
05-07 13G Hewlett Fund LP 9.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 168,750 568,546 29.68
2025-01-30 27,716 83,132 33.34
2025-01-29 63,556 124,941 50.87
2025-01-28 19,598 87,890 22.30

(click for more detail)

Similar Companies
BCLI – Brainstorm Cell Therapeutics Inc. BCTX – BriaCell Therapeutics Corp.
BFRG – Bullfrog AI Holdings, Inc. BGM – BGM Group Ltd.
BIVI – BioVie Inc.


Financial data and stock pages provided by
Fintel.io